A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset™ or placebo

Peer Review reports

Original Submission
12 Apr 2007	Submitted	Original manuscript
13 Jun 2007	Author responded	Author comments - Richard Scranton
Resubmission - Version 2
13 Jun 2007	Submitted	Manuscript version 2
Publishing
25 Jun 2007	Editorially accepted
25 Jun 2007	Article published	10.1186/1472-6823-7-3

Back to article page